Ind-Swift Laboratories is trading at ₹369.15, down 5.61%, with no clear company-specific catalyst identified for the October 8 move.
- The latest listed filing was a routine October 6 newspaper publication about relodgement of physical shares.
- The cited filing record shows no new company announcement on October 8.
- Broader risk-off pressure on October 7 included higher Treasury yields and oil prices, but available evidence does not establish a direct link to the decline.